The EpiSwitch PSE test can detect prostate cancer with 94% accuracy, which is a “significant improvement” on the most commonly used PSA test, Prostate Cancer Research said.
The MP for Richmond and Northallerton added: “I hope my work as ambassador for Prostate Cancer Research will encourage more men to be able to speak about their experience with prostate cancer and get a screening test which will hopefully prevent further needless deaths.”.
Oliver Kemp, chief executive of Prostate Cancer Research, said Mr Sunak’s “ongoing support for our mission to revolutionise prostate cancer diagnosis and treatment is invaluable”.
He added: “Men tend to ignore pain hoping it’ll go away rather than going to see the GP, and that’s a part of the reason why prostate cancer is now the most commonly diagnosed cancer in males in the UK.
More than nine out of 10 men who receive a positive EpiSwitch PSE result will have prostate cancer confirmed, said Iain Ross, executive chairman of Oxford BioDynamics.
